SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves quarterly report beat expectations and raised its full-year outlook, but the stocks reaction was muted and volatile. Traders are weighing strong AI-computing demand against heavy capital spending, debt and interest costs, and potential dilution.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is under pressure as a board investigation into CEO Jensen Huangs admitted affair with an executive at a customer brings scrutiny over possible disclosure, national-security and export-control risks; claims that the executive was linked to Chinese intelligence remain unproven. Traders are split between treating the selloff as a buying opportunity because they see the business as intact and worrying about legal or regulatory fallout and a possible CEO departure.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlists Q3 results are driving attention, with traders highlighting sharply improved gross margins and profitability from Samsung licensing revenue and stronger product margins. The reaction is broadly upbeat, but investors are debating the steep sequential drop in product sales and whether it signals reduced SK hynix supply; Micron licensing revenue expected in Q4 is seen as a possible offset.

Amprius Technologies, Inc. engages in the development, manufacture, and market of lithium-ion batteries for mobility applications, including the aviation, electric vehicle and light electric vehicle industries. It operates through the following geographical segments: North America, EMEA, and Asia Pacific. The company was founded by Mark C. Platshon in 2008 and headquartered in Fremont, CA.

Amprius Technologies Inc

Amprius quarterly results are driving attention: revenue growth and raised full-year guidance were offset by an EPS miss and negative adjusted EBITDA, prompting a sharp selloff despite many traders calling the report strong. The community is split between viewing the drop as a reaction to profitability concerns and blaming broader market weakness or short-selling.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigettis quarterly results missed expectations, prompting concern about weak commercial revenue and ongoing losses. Traders are split between skepticism that its quantum technology can translate into a viable business and optimism about its 108-qubit fidelity milestone and long-term potential.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

A Q3 earnings beat, sizable backlog and positive revenue outlook are driving attention, alongside Fireflys Synspective multi-launch agreement. Traders see contract growth as a bullish sign but remain concerned about cash burn and launch execution, with some frustrated by the muted share reaction to the results.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is drawing attention ahead of its quarterly report, with traders treating CoreWeaves strong results and raised guidance as a read-through for AI-cloud demand while debating whether NBIS can turn demand into revenue without financing or capacity-execution problems. Bulls expect a rebound across neoclouds, while skeptics point to the recent selloff and ongoing concerns about capital needs and whether good results are already priced in.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

The scheduled Nov. 22 FDA decision on Capricors Duchenne muscular dystrophy treatment Deramiocel dominates discussion, with traders weighing the HOPE-3 upper-limb results and recent AHA recognition against concerns raised during the advisory-panel review. The quarterly update is viewed as secondary; some investors were disappointed by the lack of new detail on FDA discussions, while approval optimism and bearish skepticism fuel debate around the stocks sharp swings.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

LightPaths fiscal first-quarter report is driving attention, with strong revenue growth, a record backlog and expanding gross margins drawing praise. Reactions are mixed: some traders see the results as validation of the growth story, while others point to weak after-hours trading and want clearer evidence of execution and outlook from management.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kuras Q3 update is drawing attention for accelerating KOMZIFTI uptake, with prescriptions growing faster than new patient startsa sign some traders interpret as improving patient retention and launch traction. The reaction is broadly encouraged by the commercial progress and cash runway, though competition in AML and skepticism about whether early uptake will translate into sustained growth remain part of the debate.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$OMH did okay on this one even after the split lol. 

Out full at $56. Gl

Buying $PMAX now.

$OMH 33k in for a bounce play. .113 come on 12s

StockTwits for iOS

Ohmyhome Ltd

Me Hazel

Powell Max Limited Class A Ordinary Shares

 did okay on this one even after the split lol. 

Out full at $56. Gl

Buying 